Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Kodiak Sciences Inc. (KOD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 8-K Quarterly results
08/14/2023 8-K Quarterly results
Docs: "Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating expenses Research and development $ 66,961 $ 73,744 $ 123,481 $ 149,921 General and administrative 17,871 18,324 35,966 37,914 Total operating expenses 84,832 92,068 159,447 187,835 Loss from operations Interest income 4,683 1,494 8,300 1,570 Interest expense Other income , net 187 Net loss $ $ $ $ Net loss per common share, basic and diluted $ $ $ $ Weighted-average shares of common stock outstanding used in computing net loss per common share, basic and diluted 52,378,729 52,218,773 52,358,279 52,195,972 Kodiak Sciences Inc. Condensed Consolidated Balance Sheet Data June 30, 2023 December 31, 2022 Cash, cash equivalents and marketable securities $ 378,670 $ 478,933 Working capital $ 312,717 $ 433,50..."
07/24/2023 8-K Quarterly results
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
03/28/2023 8-K Quarterly results
11/09/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
Docs: "Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating expenses Research and development $ 73,744 $ 45,404 $ 149,921 $ 85,741 General and administrative 18,324 10,505 37,914 20,726 Total operating expenses 92,068 55,909 187,835 106,467 Loss from operations Interest income 1,135 81 1,211 230 Interest expense Other income , net 310 297 Net loss $ $ $ $ Net loss per common share, basic and diluted $ $ $ $ Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted 52,218,773 51,573,894 52,195,972 51,644,946 Kodiak Sciences Inc. Condensed Consolidated Balance Sheet Data June 30, 2022 December 31, 2021 Cash, cash equivalents and marketable securities $ 597,876 $ 731,510 Working capital $ 534,536 $ 670,128 Total asse..."
08/08/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/01/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kodiak Sciences Announces Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights"
02/23/2022 8-K Results of Operations and Financial Condition, Other Events  Interactive Data
11/09/2021 8-K Quarterly results
Docs: "Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent Business Highlights"
10/15/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Excerpts from the Proxy Statement filed on September 13, 2021",
"Excerpts from the Proxy Statement filed on September 13, 2021"
09/01/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Kodiak Sciences Announces New Long-Term Performance Incentive Plan Pay for Performance: Program Aligns Incentives to Significant Value Creation through Share Price Milestones of $200 to $800 per Share"
08/09/2021 8-K Quarterly results
07/22/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "THIS AGREEMENT, dated July 22, 2021 is made and entered into by and between Edison ICAV, an Irish Collective Investment Asset-management Vehicle, acting for and on behalf of its sub-fund, the Essex Fund, as assignee of Baker Bros. Advisors, LP, a Delaware limited partnership , and Kodiak Sciences Inc., a Delaware corporation together with its Subsidiary Kodiak Sciences GmbH, a Swiss corporation and relates to a Funding Agreement dated December 1, 2019 . All capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Funding Agreement. Sellers and Buyer agree as follows: 1. the Second Payment will not be made and all references to “Purchase Price” mean One Hundred Million Dollars . Any reference to “Second Payment” is o..."
06/07/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
11/18/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and among Kodiak Sciences Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Jefferies LLC and Evercore Group L.L.C",
"Opinion of Cooley LLP"
11/09/2020 8-K Quarterly results
Docs: "Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019"
08/20/2020 8-K Quarterly results
08/10/2020 8-K Quarterly results
06/25/2020 8-K Quarterly results
06/09/2020 8-K Submission of Matters to a Vote of Security Holders
Docs: "FORM 8-K"
05/11/2020 8-K Quarterly results
Docs: "Three Months Ended March 31, 2020 2019"
04/03/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/16/2020 8-K Quarterly results
12/19/2019 8-K Quarterly results
12/04/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 3, 2019 KODIAK SCIENCES INC. Delaware 001-38682 27-0476525 2631 Hanover Street Palo Alto, CA 94304 Registrant's telephone number, including area code: 281-0850 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commence...",
"Underwriting Agreement, by and among Kodiak Sciences Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Jefferies LLC",
"Opinion of Cooley LLP"
12/02/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Funding Agreement, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Baker Bros. Advisors, LP",
"Funding Agreement, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Baker Bros. Advisors, LP"
11/20/2019 8-K Quarterly results
11/12/2019 8-K Quarterly results
Docs: "Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy